A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Effective treatments for alcohol dependence exist; however, they remain underused and are not effective, or suitable, for all ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

"In the case of oral semaglutide for overweight/obesity, it appears that 25 mg a day is that dose." The trial enrolled 243 participants with a BMI of at least 30, or 27 with a weight-related ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

About The Study: Among patients with alcohol use disorder (AUD) and comorbid obesity/type 2 diabetes, the use of semaglutide and liraglutide were associated with a substantially decreased risk of ...